NASDAQ:GPCR
Structure Therapeutics
- Stock
Last Close
33.47
06/11 21:01
Market Cap
2.25B
Beta: -
Volume Today
656.36K
Avg: 1.02M
PE Ratio
−22.22
PFCF: −22.62
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|
average inventory | |||||
average payables | 2.51M - | 4.75M 89.44% | 5.38M 13.25% | ||
average receivables | |||||
book value per share | -0.00 - | -0.00 183.26% | -3.01 118,413.94% | 4.11 236.53% | |
capex per share | -0.00 - | -0.00 6,140.49% | -0.00 8,463.80% | -0.02 385.19% | |
capex to depreciation | -16.75 - | -0.56 96.66% | -7.35 1,212.76% | ||
capex to operating cash flow | 0.00 - | 0.04 2,719.01% | 0.00 91.04% | 0.03 711.18% | |
capex to revenue | |||||
cash per share | 0.00 - | 0.00 181.75% | 4.07 96,513.72% | 4.24 4.23% | |
days of inventory on hand | |||||
days payables outstanding | |||||
days sales outstanding | |||||
debt to assets | 0.01 - | 0.01 22.77% | 0.00 52.44% | 0.01 325.73% | |
debt to equity | -0.01 - | -0.01 23.02% | -0.00 76.46% | 0.01 633.12% | |
dividend yield | |||||
earnings yield | -0.00 - | -0.00 135.63% | -0.05 89,774.03% | -0.02 61.34% | |
enterprise value | 651.36M - | 662.43M 1.70% | 903.74M 36.43% | 4.37B 383.25% | |
enterprise value over ebitda | -40.95K - | -17.61K 57.01% | -17.19 99.90% | -42.49 147.14% | |
ev to operating cash flow | -45.60K - | -20.60K 54.83% | -19.60 99.90% | -54.94 180.39% | |
ev to sales | |||||
free cash flow per share | -0.00 - | -0.00 129.37% | -1.21 92,311.21% | -0.74 38.76% | |
free cash flow yield | -0.00 - | -0.00 129.37% | -0.05 92,311.21% | -0.02 60.94% | |
graham net net | -0.00 - | -0.00 184.17% | -1.50 55,661.24% | 3.98 365.01% | |
graham number | 0.00 - | 0.01 158.35% | 9.53 103,105.26% | 8.67 9.04% | |
income quality | 0.90 - | 0.85 6.05% | 0.90 6.32% | 0.89 1.30% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | |
interest coverage | 34.26 - | -7.67 122.40% | |||
interest debt per share | 0.00 - | 0.00 118.05% | -0.03 136,797.38% | 0.17 613.31% | |
inventory turnover | |||||
invested capital | -0.01 - | -0.01 23.02% | -0.00 76.46% | 0.01 633.12% | |
market cap | 651.38M - | 662.54M 1.71% | 994.32M 50.08% | 4.49B 351.73% | |
net current asset value | -22.75K - | -66.64K 192.87% | -119.90M 179,815.97% | 444.56M 470.79% | |
net debt to ebitda | 1.01 - | 2.78 175.36% | 1.72 38.06% | 1.21 29.80% | |
net income per share | -0.00 - | -0.00 135.63% | -1.34 89,774.03% | -0.81 39.40% | |
operating cash flow per share | -0.00 - | -0.00 121.37% | -1.21 95,455.49% | -0.72 40.19% | |
payables turnover | |||||
receivables turnover | |||||
research and ddevelopement to revenue | |||||
return on tangible assets | -0.41 - | -0.34 16.55% | -0.52 53.23% | -0.19 64.55% | |
revenue per share | |||||
roe | 0.71 - | 0.59 16.81% | 0.45 24.17% | -0.20 144.39% | |
roic | 0.73 - | 0.60 18.44% | 0.46 23.20% | -0.22 148.43% | |
sales general and administrative to revenue | |||||
shareholders equity per share | -0.00 - | -0.00 183.26% | -3.01 118,413.94% | 4.11 236.53% | |
stock based compensation to revenue | |||||
tangible asset value | -22.47K - | -64.73K 188.11% | -115.14M 177,763.60% | 452.97M 493.40% | |
tangible book value per share | -0.00 - | -0.00 183.26% | -3.01 118,413.94% | 4.11 236.53% | |
working capital | 35.38K - | 100.59K 184.32% | 80.08M 79,507.72% | 448.87M 460.53% |
All numbers in USD (except ratios and percentages)